TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.

Kamal Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.